Login to Your Account

Celgene Plunks Down Potential $935M for Avila Therapeutics

By Marie Powers
Staff Writer

Friday, January 27, 2012
Robert Hugin, chairman and CEO of Celgene Corp., wasn't kidding when he told attendees at this month's J.P. Morgan Healthcare Conference that 2011 was a "year of momentum" for the giant biotech. (See BioWorld Today, Jan. 10, 2012.)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription